Endo announces delivery of authorised generic PROVENTIL (albuterol sulfate) in the US
8 April 2019 -

Irish pharmaceutical company Endo International plc (NASDAQ:ENDP) reported on Friday the start of shipment of an authorised generic version PROVENTIL (albuterol sulfate) HFA Inhalation Aerosol, 120mcg .

This shipment was initiated by one of the company's operating companies, Par Pharmaceutical (Par).

PROVENTIL is reportedly a registered trademark of Merck Sharp & Dohme Corp.

Recently, Endo Procurement Operations Limited signed an exclusive US supply and distribution agreement with a subsidiary of Merck & Co Inc of Kenilworth, N.J, under which, Par will launch and distribute an authorised generic of PROVENTIL.